PETCT imaging in pancreatic neoplasm: FDG and non-FDG tracers

Author(s): Dr Sai Sradha Patro, Dr Kanhaiyalal Agrawal, Dr Gopinath Gnanasegaran

Hospital: AIIMS India, Royal Free London NHS Foundation Trust

Reference: RAD Magazine, 48, 568, 21-14


Pancreatic cancer is considered the 10th most common malignancy globally with a poor prognosis (fourth most common cause of overall cancer deaths). The most common age at diagnosis is 65-74 years. The five-year survival rate is approximately 11.5% as per the latest SEER 17 data (ranging from 44% for localised disease to 3% for distant metastases). Therefore, early diagnosis is vital as it impacts prognosis and survival despite all the treatment options available. Imaging techniques are essential for diagnosis, staging, response evaluation and post-treatment surveillance.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read more